State of the Art: Newer Biomarkers in Heart Failure
Open Access
- 16 April 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 17 (6) , 559-569
Abstract
Since natriuretic peptides were successfully integrated into the clinical practice of heart failure (HF), the possibility of using new biomarkers to advance the management of affected patients has been explored. While a huge number of candidate HF biomarkers have been described recently, very few have made the difficult translation from initial promise to clinical application. These markers mirror the complex pathophysiology of heart failure at various levels: cell loss (troponin), fibrosis (ST2 and galectin-3), infection (procalcitonin), and renal disease (several renal markers). In this review, we examine the best emerging candidates for clinical assessment and management of patients with HF.Keywords
This publication has 109 references indexed in Scilit:
- Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureJournal of Molecular and Cellular Cardiology, 2013
- Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly PopulationJACC, 2013
- Use of Procalcitonin for the Diagnosis of Pneumonia in Patients Presenting with a Chief Complaint of Dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) TrialEuropean Journal of Heart Failure, 2012
- Plasma Neutrophil Gelatinase–Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older AdultsJACC, 2012
- Prognostic Utility of Plasma Neutrophil Gelatinase-Associated Lipocalin in Patients with Acute Heart Failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in Acutely Decompensated Heart Failure (GALLANT) TrialEuropean Journal of Heart Failure, 2011
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and SurvivalThe American Journal of Cardiology, 2011
- Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection FractionThe American Journal of Cardiology, 2011
- Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older AdultsJAMA, 2010
- Galectin-3, Cardiac Structure and Function, and Long-Term Mortality in Patients with Acutely Decompensated Heart FailureEuropean Journal of Heart Failure, 2010
- Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older AdultsJACC, 2008